Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Zimmer Holdings, Inc.    ZMH   US98956P1021

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/20/2014 11/21/2014 11/24/2014 11/25/2014 11/26/2014 Date
110.12(c) 110.48(c) 110.08(c) 111.08(c) 111.63 Last
985 701 821 242 1 355 368 923 555 588 265 Volume
-0.39% +0.33% -0.36% +0.91% +0.50% Change
More quotes
Company
Zimmer Holdings, Inc. designs, develops, manufactures, and markets orthopedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products.The company also provides other healthcare related services.The Orthopedic reconstructive devices restore function lost... 
Sector
Medical Equipment, Supplies & Distribution
Calendar
12/02 | 08:00amPresentation
Surperformance© rating of Zimmer Holdings, Inc.
Trading Rating : Investor Rating :
More about the company
Chart ZIMMER HOLDINGS, INC.
Duration : Period :
Zimmer Holdings, Inc. Technical Analysis Chart | ZMH | US98956P1021 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 4 697 M
EBIT 2014 1 429 M
Net income 2014 830 M
Debt 2014 288 M
Yield 2014 0,82%
Sales 2015 4 820 M
EBIT 2015 1 513 M
Net income 2015 1 001 M
Finance 2015 67,8 M
Yield 2015 0,89%
PER 2014 22,15
PER 2015 18,85
EV / Sales 2014 4,07x
EV / Sales 2015 3,89x
Capitalization 18 812 M
More Financials
Latest news on ZIMMER HOLDINGS, INC.
6d ago ZIMMER : Spine Showcases its Expanding Business and a Dozen New Products at the ..
11/19 ZIMMER : Nov 19, 2014 Synovasure® PJI Test Earns Certification To Clear Way For ..
11/19 ZIMMER : Extends Review of Proposed Biomet Merger
11/18 ZIMMER : Nov 18, 2014 Zimmer Provides Update on the European Commission Review P..
11/18 ZIMMER : Other Events, Financial Statements and Exhibits (form 8-K)
11/17 ZIMMER : Nov 17, 2014 Zimmer's Virage® OCT Spinal Fixation System Wins Life Scie..
11/12 ZIMMER : Nov 12, 2014 Zimmer Spine Showcases its Expanding Business and a Dozen ..
11/10 ZIMMER : Nov 10, 2014 Zimmer Announces FDA Clearance of the Stand-alone Optio-C®..
11/05 ZIMMER : Management's Discussion and Analysis of Financial Condition and Results..
11/05 ZIMMER : Entry into a Material Definitive Agreement, Financial Statements and Ex..
10/30 ZIMMER : will become Zimmer Biomet after acquisition
10/30 ZIMMER : Change in Directors or Principal Officers, Other Events, Financial Stat..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF